CRT 2026
Heart Failure
JoAnn Lindenfeld, MD
Director, Heart Failure and Transplantation
Vanderbilt University
Nashville, Tennessee, United States
Disclosure(s): Abbott Labs: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); AbioMed: Consulting Fees (e.g., advisory boards) (Ongoing); Alleviant Medical: Consulting Fees (e.g., advisory boards) (Ongoing); AskBio: Consulting Fees (e.g., advisory boards) (Ongoing); Axon: Consulting Fees (e.g., advisory boards) (Ongoing); Boston Scientific: Consulting Fees (e.g., advisory boards) (Ongoing); Cordio: Consulting Fees (e.g., advisory boards) (Ongoing); CVRx: Consulting Fees (e.g., advisory boards) (Ongoing); Edwards Lifesciences: Consulting Fees (e.g., advisory boards) (Ongoing); Intershunt,: Consulting Fees (e.g., advisory boards) (Ongoing); Kestra: Consulting Fees (e.g., advisory boards) (Ongoing); Medtronic: Consulting Fees (e.g., advisory boards) (Ongoing); Merck Pharmaceuticals: Consulting Fees (e.g., advisory boards) (Ongoing); OrchestraBiomed: Consulting Fees (e.g., advisory boards) (Ongoing); Vectorious: Consulting Fees (e.g., advisory boards) (Ongoing); Volumetrix: Consulting Fees (e.g., advisory boards) (Ongoing); VWave: Consulting Fees (e.g., advisory boards) (Ongoing); Whiteswell: Consulting Fees (e.g., advisory boards) (Ongoing)